Enteric Disease Testing Market is expected to grow at a CAGR of 3.5% during the forecast period and market is expected to reach US$ 2.37 Bn. by 2029.Enteric Disease Testing Market Overview:
Microorganisms such as viruses, bacteria, and parasites that cause gastro-intestinal illness are known as enteric diseases. Consumption of contaminated food or water causes these diseases. These diseases are sometimes passed from person to person.To know about the Research Methodology :- Request Free Sample Report
Enteric Disease Testing Market Dynamics:
Rising prevalence of Cholera worldwide is the major factor driving the market growth. Over the forecast period, the global enteric disease testing market is predicted to rise due to the high prevalence of cholera. In addition, an enteric disease outbreak is predicted to increase demand for enteric disease diagnostics. In August 2021, a salmonella outbreak was recorded in 47 states across the United States. In the third week of August, the Centers for Disease Control and Prevention stated that the number of recorded cases of salmonella newport infections had risen to 869, with 116 hospitalizations in 47 states. The enteric disease testing market is predicted to grow in response to increased government activities to raise public awareness about adequate sanitation, hygiene, and enteric infections. Due to a weakened immune system, young children, newborns, individuals with disabilities, and the aged people are the most vulnerable to enteric infections. These disorders have to be recognised early in order to limit the risk of consequences. As a result, the rising geriatric population contributes to market growth. Previously, the diagnostic process for enteric diseases was dependent on conventional methods, which required specialised personnel and was a time-consuming procedure, resulting in increased death rates. These considerations, along with the cost-efficiency of technologically improved diagnostic systems, are driving demand for enteric disease testing. The key players and academic institutions have created an isothermal nucleic acid amplification-based diagnostic approach that uses enzymes to combine all of the temperature-dependent steps of PCR. Because this technology is so particular and sensitive, it may be used by healthcare facilities all over the world to identify and detect diseases quickly. This technique is expected to impose a positive impact on the market growth. The report has profiled twenty-one key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.Enteric Disease Testing Market Segment Analysis:
The Global Enteric Disease Testing Market is segmented on the basis of Disease Type, Test Type and End-Users. Based on Disease Type, the Bacterial Enteric Diseases segment accounts for a major market share. It involves various types of bacteria such as C. difficile, E. coli, Shigella, Salmonella, and Campylobacter. Enteric bacteria enter the body most commonly through the mouth. They are spread by contaminated food and drink, contact with animals or their habitats, and contact with an infected person's excrement. The segment accounted for more than 60% market share in 2022. Enteric bacteria can cause a chronic infection of the intestine, causing diarrhoea and weakening of the digestive tract. Cholera is predicted to affect 1,72,454 individuals worldwide each year, resulting in a higher fatality rate, states the WHO. Currently, there are vaccinations with higher efficacy that have demonstrated to be effective in treating bacterial enteric illnesses. As a result, the increasing availability of better treatment alternatives will propel the segment forward. Based on Test Type, the molecular diagnostics segment is anticipated to dominate the global market. Traditional diagnostic approaches have been gradually replaced by newer quick antigen detection and molecular-based procedures as molecular diagnostics has progressed and commercially available assays have been available. Clostridioides difficile is the most common cause of nosocomial and antibiotic-related diarrhoea, as well as pseudomembranous colitis. C. difficile infection can be diagnosed using a number of FDA-approved procedures. AmpliVue C. difficile is a semiautomated assay that uses isothermal helicase-dependent amplification and hybridization in a cartridge/chip-based format (Quidel Diagnostics, San Diego, CA, USA). The United States, Canada, Japan, China, and Europe are expected to fuel the global Molecular Diagnostic Testing segment by registering a CAGR of 2% during the forecast period. China is anticipated to grow at a faster rate. The Asia-Pacific market is expected to reach US$607.7 million by 2029, led by countries like Australia, India, and South Korea.Enteric Disease Testing Market Regional Insights:
North America is expected to dominate the global market during the forecast period. North America accounted for a market share of 30% in 2022. Because of the high cost of products and a high degree of customer awareness, North America dominates the market. In the United States, the market for enteric disease testing is expected to exceed $1 billion during the forecast period. Due to an increase in gastrointestinal illness diagnostic rates, multiple market players in the United States, technological improvements, significant R&D activities, and increased awareness about the disease the region is anticipated to grow at a significant rate. The report also helps in understanding the Global Enteric Disease Testing Market dynamics, structure by analyzing the market segments and project the Global Enteric Disease Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Enteric Disease Testing Market make the report investor’s guide.Enteric Disease Testing Market, Key Developments:
ERADA Technology Alliance Ltd. (ERADA) launched the Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART), a saliva-based diagnostic tool for detecting parasites that cause malaria in March 2021.Global Enteric Disease Testing Market Scope: Inquire before buying
Global Enteric Disease Testing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.86 Bn. Forecast Period 2023 to 2029 CAGR: 3.5% Market Size in 2029: US $ 2.37 Bn. Segments Covered: By Disease Type Bacterial Enteric Diseases Viral Enteric Diseases Parasitic Enteric Diseases By Test Type Immunoassay testing Conventional testing Molecular diagnostic testing By End-Users Hospitals Research Labs Diagnostic Laboratories Enteric Disease Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Enteric Disease Testing Market Key Players are:
1.Alere Inc 2.Bio-Rad Laboratories 3.Quest Diagnostics 4.Becton Dickinson and Company 5.Cepheid 6.DiaSorin 7.Meridian BioSciences 8.Coris BioConcept 9.Trinity Biotech 10.Thermo Fisher Scientific Inc. 11.Mobidiag Ltd. 12.R-Biopharm 13.GlaxoSmithKline plc 14.Bharat Biotech 15.Sanofi 16.Janssen Global Services, LLC 17.Eli Lilly and Company 18.IDL Biotech AB (publ) 19.Merck & Co., Inc. 20.Novartis AG 21.Takeda Pharmaceutical Company Frequently Asked Questions: 1. Which region has the largest share in Enteric Disease Testing Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Enteric Disease Testing Market? Ans: The Global Enteric Disease Testing Market is growing at a CAGR of 3.5% during forecasting period 2023-2029. 3. What is scope of the Global Enteric Disease Testing market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Enteric Disease Testing market? Ans: The important key players in the market are – Alere Inc, Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid, DiaSorin, Meridian BioSciences, Coris BioConcept, Trinity Biotech, Thermo Fisher Scientific Inc., Mobidiag Ltd., R-Biopharm, GlaxoSmithKline plc, Bharat Biotech, Sanofi, Janssen Global Services, LLC, Eli Lilly and Company, IDL Biotech AB (publ), Merck & Co., Inc., Novartis AG, and Takeda Pharmaceutical Company 5. What is the study period of this market? Ans: The Global market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Enteric Disease Testing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Enteric Disease Testing Market 3.4. Geographical Snapshot of the Enteric Disease Testing Market, By Manufacturer share 4. Global Enteric Disease Testing Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Enteric Disease Testing Market 5. Supply Side and Demand Side Indicators 6. Global Enteric Disease Testing Market Analysis and Forecast, 2022-2029 6.1. Global Enteric Disease Testing Market Size & Y-o-Y Growth Analysis. 7. Global Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 7.1.1. Bacterial Enteric Diseases 7.1.2. Viral Enteric Diseases 7.1.3. Parasitic Enteric Diseases 7.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 7.2.1. Immunoassay testing 7.2.2. Conventional testing 7.2.3. Molecular diagnostic testing 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 7.3.1. Hospitals 7.3.2. Research Labs 7.3.3. Diagnostic Laboratories 8. Global Enteric Disease Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 9.1.1. Bacterial Enteric Diseases 9.1.2. Viral Enteric Diseases 9.1.3. Parasitic Enteric Diseases 9.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 9.2.1. Immunoassay testing 9.2.2. Conventional testing 9.2.3. Molecular diagnostic testing 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 9.3.1. Hospitals 9.3.2. Research Labs 9.3.3. Diagnostic Laboratories 10. North America Enteric Disease Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 12. Canada Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 13. Mexico Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 14. Europe Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 15. Europe Enteric Disease Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 17. France Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 18. Germany Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 19. Italy Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 20. Spain Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 21. Sweden Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 22. CIS Countries Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 23. Rest of Europe Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 24. Asia Pacific Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 25. Asia Pacific Enteric Disease Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 27. India Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 28. Japan Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 29. South Korea Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 30. Australia Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 31. ASEAN Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 32. Rest of Asia Pacific Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 33. Middle East Africa Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 34. Middle East Africa Enteric Disease Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 36. GCC Countries Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 37. Egypt Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 38. Nigeria Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 39. Rest of ME&A Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 40. South America Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 41. South America Enteric Disease Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 43. Argentina Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 44. Rest of South America Enteric Disease Testing Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Enteric Disease Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Alere Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Bio-Rad Laboratories 45.3.3. Quest Diagnostics 45.3.4. Becton Dickinson and Company 45.3.5. Cepheid 45.3.6. DiaSorin 45.3.7. Meridian BioSciences 45.3.8. Coris BioConcept 45.3.9. Trinity Biotech 45.3.10. Thermo Fisher Scientific Inc. 45.3.11. Mobidiag Ltd. 45.3.12. R-Biopharm 45.3.13. GlaxoSmithKline plc 45.3.14. Bharat Biotech 45.3.15. Sanofi 45.3.16. Janssen Global Services, LLC 45.3.17. Eli Lilly and Company 45.3.18. IDL Biotech AB (publ) 45.3.19. Merck & Co., Inc. 45.3.20. Novartis AG 45.3.21. Takeda Pharmaceutical Company 46. Primary Key Insights